Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice

Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices. 2021-05-28 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19Interim Order No. 2noticeclinical trialsmedical devicesdrugsauthorization to conduct clinical trials Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: NoticeHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/interim-order-2-clinical-trials-medical-devices-drugs/notice.html Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: NoticeHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/arrete-urgence-no-2-cliniques-instruments-medicaux-drogues/note-explanative/avis.html

IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices.

Data and Resources

Similar records